Cargando…

Impact of sex and APOE ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults

INTRODUCTION: Cognitive decline follows pathological changes including neurodegeneration on the Alzheimer's disease continuum. However, it is unclear which cognitive domains first become affected by neurodegeneration in amyloid‐positive individuals and if sex or apolipoprotein (APOE) ε4 status...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Kellen K., Grober, Ellen, Lipton, Richard B., Sperling, Reisa A., Buckley, Rachel F., Aisen, Paul S., Ezzati, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828988/
https://www.ncbi.nlm.nih.gov/pubmed/35155730
http://dx.doi.org/10.1002/dad2.12271
Descripción
Sumario:INTRODUCTION: Cognitive decline follows pathological changes including neurodegeneration on the Alzheimer's disease continuum. However, it is unclear which cognitive domains first become affected by neurodegeneration in amyloid‐positive individuals and if sex or apolipoprotein (APOE) ε4 status differences affect this relationship. METHODS: Data from 1233 cognitively unimpaired, amyloid‐positive individuals 65 to 85 years of age were studied to assess the effect of hippocampal volume (HV) on cognition and to evaluate differences due to sex and APOE ε4 status. RESULTS: Lower HV was linked with worse performance on measures of memory (free recall, total recall, logical memory delayed recall, Mini‐Mental State Examination [MMSE]), executive functioning (digit symbol substitution, DSS), and the Preclinical Alzheimer's Cognitive Composite (PACC). Among both women and APOE ε4+ individuals, all cognitive measures, except MMSE, were associated with HV. DSS and PACC had the largest effect sizes in differentiating early and intermediate stage neurodegeneration. DISCUSSION: Despite all cognitive measures being associated with HV, cognitive tests show differences in detecting early or late signs of neurodegeneration. Differences exist in association between cognition and neurodegeneration based on sex and APOE ε4 status